Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Price Target at $33.00
Shares of Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six analysts that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1 […]
Shares of Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six analysts that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1 […]